Anders Wimo Selected Research

Patient Care

6/2022	Cost of Diagnosing and Treating Cognitive Complaints: One-year Cost-evaluation Study in a Patient Cohort from a Slovenian Memory Clinic.
2/2021	A validation study of the CarerQol instrument in informal caregivers of people with dementia from eight European countries.
1/2019	Classification tree model of the personal economic burden of dementia care by related factors of both people with dementia and caregivers in Japan: a cross-sectional online survey.
6/2018	The personal cost of dementia care in Japan: A comparative analysis of residence types.
1/2018	Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.
1/2018	Costs of Care of Agitation Associated With Dementia in 8 European Countries: Results From the RightTimePlaceCare Study.
11/2017	Costs of dementia in the Czech Republic.
1/2017	Erratum to: The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care.
12/2016	Cost of Dementia and Its Correlation With Dependence.
11/2016	The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders Wimo Research Topics

Disease

33	Dementia (Dementias) 06/2022 - 09/2002
25	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2002
12	Cognitive Dysfunction 06/2022 - 01/2004
3	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2018 - 09/2015
2	Parkinson Disease (Parkinson's Disease) 11/2017 - 09/2015
2	Frontotemporal Dementia (Semantic Dementia) 11/2017 - 09/2015
2	Pain (Aches) 01/2017 - 01/2016
2	Heart Failure 07/2006 - 12/2003
1	Frailty 01/2020
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2020
1	Sarcopenia 01/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020
1	Disease Progression 10/2019
1	Lewy Body Disease (Lewy Body Dementia) 11/2017
1	Chronic Pain 01/2017
1	Myocardial Infarction 09/2013
1	Drug-Related Side Effects and Adverse Reactions 01/2005

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2018 - 08/2015
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021 - 01/2002
3	Galantamine (Galanthamine)FDA LinkGeneric 01/2021 - 01/2002
3	Amyloid (Amyloid Fibrils)IBA 12/2015 - 12/2012
3	Pharmaceutical PreparationsIBA 08/2015 - 07/2006
2	Apolipoproteins E (ApoE)IBA 01/2018 - 09/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2006 - 12/2003
2	Donepezil (Aricept)FDA LinkGeneric 08/2004 - 01/2003
2	Memantine (Namenda)FDA Link 12/2003 - 01/2003
1	Antipsychotic Agents (Antipsychotics)IBA 01/2018
1	ApolipoproteinsIBA 01/2018
1	Serum AlbuminIBA 11/2017
1	ORALIT (ORS)IBA 01/2016
1	Rivastigmine (Exelon)FDA LinkGeneric 05/2007
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2003
1	Neuroprotective AgentsIBA 12/2003

Therapy/Procedure

18	Patient Care 06/2022 - 09/2002
11	Activities of Daily Living (ADL) 01/2020 - 09/2002
6	Home Nursing (Nursing, Home) 06/2022 - 01/2016
3	Therapeutics 10/2019 - 07/2007
1	Critical Care (Surgical Intensive Care) 01/2022
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020
1	Canes (Cane) 01/2018
1	Long-Term Care 01/2018
1	Pain Management 01/2017
1	Secondary Prevention 01/2017
1	Length of Stay 01/2016
1	Immunotherapy 12/2012
1	Inappropriate Prescribing 01/2005